Insulin signaling
Receptor autophosphorylation, IRS docking, PI3K/PIP3, PDK1/mTORC2-AKT, AS160/TBC1D4, FOXO1, GSK3, mTOR, MAPK, PTEN, and PTP1B, in sequence.
Education First
Site section 6 of 12A research-first course on sugar-to-signal biology, insulin receptor pathways, GLUT4 trafficking, tissue-specific resistance, lipid and organelle stress, inflammatory crosstalk, downstream excess-glucose chemistry, islet compensation, measurement, and catalog boundaries.
Learning progress
Progress is private to this browser.
Glucose disposal model
How a saturating response to an insulin signal flattens as sensitivity falls, so that the same disposal needs more signal, the mechanism behind compensation indices.
Modeled disposal
91% of ceiling
at the scrubbed insulin signal
Half-maximal signal
1.00arbitrary
1 / Si; 1.00 × the signal Si = 1 needs
Signal for 90 percent
9.0arbitrary
9 / Si
Disposal at the plot edge
95% of ceiling
at an insulin signal of 20
An intermediate sensitivity
At Si 1.00 the model reaches half of its ceiling at an insulin signal of 1.00, 1.00 times the signal Si = 1 needs, reaches 90 percent at 9.0, and reads 95 percent at the edge of the plot. At the scrubbed signal of 10.0 disposal is 91 percent of the ceiling. Lower Si to watch the curve flatten and the half-maximal point move right.
Insulin sensitivity 1.00, insulin signal 10.0. Modeled disposal 91 percent of the ceiling. Half of the ceiling needs 1.00 times the insulin of Si 1; 90 percent needs a signal of 9.0; the plot edge reads 95 percent.
disposal = Si × x / (1 + Si × x); a fraction f of the ceiling is reached at x = f / ((1 − f) × Si)
What it shows: A Michaelis-style saturation: disposal rises with the insulin signal x and approaches the model ceiling of 1. Si sets how quickly it climbs; the half-maximal point 1 / Si and the 90 percent point 9 / Si move right as Si falls.
How to read it: The curve is the model at the set Si over an insulin signal of 0 to 20; the cursor reads disposal at the scrubbed signal. The dashed reference marks the half-maximal point and the dashed top line the ceiling the curve approaches. The half-maximal signal is also the compensation multiplier against Si = 1, whose half-maximal signal is 1.
Assumptions: One saturating step with no threshold, no time course and no counter-regulation. The insulin axis is in arbitrary units and disposal is a fraction of the model’s own ceiling. Clinical indices such as HOMA-IR are estimated from fasting glucose and insulin by a different, calibrated model.
A saturating curve rising from the origin and bending toward a dashed ceiling, on ticked axes, with a dashed reference at its half-maximal point and a cursor at the scrubbed insulin signal.
Check yourself
A learner sees glucose, insulin signaling, adipose flux, and islet feedback and wants a personal plan. The course must force the question back to mechanism, readout type, and boundary.
Choose the next move
Pick an answer to see why.
Course spine
The course starts with normal glucose and insulin biology, then builds toward tissue-specific resistance, downstream glucose-exposure chemistry, feedback loops, measurement limits, and catalog boundaries.
01 / Orientation
Define insulin resistance as tissue-specific loss of insulin-signal fidelity, not a single on/off state.
02 / Sugar to signal
Trace absorbable carbohydrate exposure through glucose appearance, insulin secretion, and tissue fuel partitioning without giving dietary guidance.
03 / Receptor network
Map insulin receptor, IRS, PI3K, PIP3, AKT, AS160/TBC1D4, FOXO1, GSK3, mTOR, MAPK, and phosphatase control nodes.
04 / GLUT4 trafficking
Explain insulin-stimulated GLUT4 vesicle movement in skeletal-muscle and adipose model systems.
05 / Tissue atlas
Separate skeletal muscle, liver, adipose tissue, islet, endothelium, immune-stromal, brain, and bone contexts.
06 / Initiation
Describe adipose buffering limits, lipolysis escape, fatty-acid flux, and ectopic lipid as early system stressors.
07 / Liver divergence
Explain selective hepatic insulin resistance: incomplete glucose-output suppression with persistent lipid-program signals.
08 / Organelle stress
Connect DAG, ceramide, PKC, mitochondria, ROS, ER stress, and incomplete substrate handling to signaling interference.
09 / Inflammatory crosstalk
Show how JNK, IKK/NF-kB, SOCS, PTP1B, mTOR/S6K, cytokines, and nutrient-stress nodes can intersect IRS signaling.
10 / Sustained glucose exposure
Teach nonenzymatic glycation, AGE/RAGE, polyol flux, hexosamine signaling, PKC, oxidative stress, capillary biology, immune shifts, bone matrix context, retina, kidney-like barriers, nerves, and beta-cell glucotoxicity.
11 / Islet feedback
Place hyperinsulinemia, beta-cell compensation, secretory load, insulin clearance, and decompensation into a feedback map.
12 / Measurement
Match readout categories to the mechanism they can observe and the inference they cannot prove alone.
13 / Catalog boundary
Keep catalog records limited to identity, structural context, analytical documentation, and reading a certificate.
14 / Capstone
Assemble a full map from carbohydrate exposure to tissue-specific resistance, downstream glucose exposure, feedback loops, and measurement limits.
What this course covers
Normal insulin action comes first, then tissue-specific resistance, then the downstream chemistry of excess glucose exposure. Catalog material stays outside the mechanism claim, and no chapter offers diagnosis, prevention, management, supplement, dosing, or route guidance.
Receptor autophosphorylation, IRS docking, PI3K/PIP3, PDK1/mTORC2-AKT, AS160/TBC1D4, FOXO1, GSK3, mTOR, MAPK, PTEN, and PTP1B, in sequence.
Muscle glucose disposal, hepatic glucose output, adipose anti-lipolysis, islet feedback, endothelial signaling, immune-stromal tone, and bone matrix context, each on its own.
The downstream layer: glycation, AGE/RAGE, the polyol pathway, hexosamine flux, PKC activation, oxidative stress, capillary barriers, retina, nerve, kidney-like filtration, and bone collagen effects.
Clamps, tracers, OGTT curves, phosphoproteomics, lipidomics, cell assays, imaging, and histology, each tied to what it can and cannot establish.
Chapter 01
Define insulin resistance as tissue-specific loss of insulin-signal fidelity, not a single on/off state.
The useful question is not whether insulin exists. It is whether each tissue receives, routes, and answers the signal with the right strength and timing.
Muscle, liver, adipose tissue, islet, endothelium, immune-stromal tissue, bone, retina-like barriers, and nerves have different insulin and glucose-exposure problems.
Hyperinsulinemia, fatty-acid spillover, inflammation, capillary stress, glucose-derived chemistry, and beta-cell load can become self-reinforcing loops.
Chapter 02
Trace absorbable carbohydrate exposure through glucose appearance, insulin secretion, and tissue fuel partitioning without giving dietary guidance.
Signal 01
Absorbable carbohydrate can appear in circulation as glucose. Sucrose also carries fructose, which routes through intestinal and hepatic handling rather than the same insulin-regulated GLUT4 pathway.
Signal 02
Rising glucose increases beta-cell secretory demand. Insulin then helps coordinate fuel storage, glucose uptake, anti-lipolysis, and hepatic glucose-output suppression.
Signal 03
Muscle, liver, adipose tissue, endothelium, immune cells, bone cells, neural tissue, and islets do not experience the same insulin job or the same stress threshold.
Signal 04
When exposure is high, repeated, or paired with impaired buffering, the system can shift toward hyperinsulinemia, lipid spillover, oxidative stress, and glucose-derived chemical stress.
The rising-then-saturating shape that links a growing input to a bounded response recurs across this biology: glucose appearance driving insulin secretion, insulin signal driving disposal. Drive the general model below to feel that shape. The axes carry no real numbers and it is not measured data for glucose, insulin, or any lot.
Dose-response, the model
How a response climbs from a threshold to a ceiling as concentration rises: EC50 shifts the curve, the Hill slope changes its width, and Emax sets the ceiling; the rise from a tenth to nine tenths spans 81^(1/n) in concentration.
Response
50%
on the response axis, the value under the needle (climbing); 50 % of the ceiling you set
Ten-to-ninety span
18.72fold
81^(1/n) in concentration; the dashed n = 1 reference spans 81 fold
At the half-maximal point
The scrubbed concentration sits at the EC50 you set, so the model returns half of its own ceiling (50 percent here, at the scrub’s resolution). This is the inflection of the curve on the log-concentration axis, where the climb is at its steepest.
In this model, with the scrubbed concentration at the EC50 you set, the response axis reads 50 percent, which is 50 percent of the ceiling you set. EC50 and slope are parameters you set, not measured for this lot.
response = Emax / (1 + 10^(n (log EC50 − log C)))
What it shows: The general S-shaped relationship many chemical sequences are described by: as concentration rises the response stays near zero, then climbs, then flattens at a ceiling. The midpoint of the climb is the EC50, the half-maximal point.
How to read it: Move EC50 to shift the whole curve left or right, raise the Hill slope n to sharpen the climb (the dashed curve keeps the slope of one for reference), lower Emax to drop the ceiling, and scrub on the plot or with the control to read the model fraction at any concentration. The concentration axis carries no numbers on purpose: the shape is the point.
Assumptions: A single Hill relationship with one EC50 and one slope; no measured concentration, response, EC50 or ceiling for any lot; no variance, so no uncertainty band is drawn.
A sigmoid on a numberless concentration axis rising from near zero to the ceiling you set. A caret on the axis marks the EC50 you set; a bracket above the field spans the rise from a tenth to nine tenths of the ceiling; the needle sits at the concentration you scrubbed. When the Hill slope is not one, a dashed reference curve shows the same EC50 and ceiling at a slope of one.
Chapter 03
Map insulin receptor, IRS, PI3K, PIP3, AKT, AS160/TBC1D4, FOXO1, GSK3, mTOR, MAPK, and phosphatase control nodes.
Chapter 04
Explain insulin-stimulated GLUT4 vesicle movement in skeletal-muscle and adipose model systems.
In skeletal-muscle and adipose model systems, GLUT4 is stored in specialized intracellular vesicles before insulin stimulation.
AKT can regulate AS160/TBC1D4 and Rab-like trafficking machinery, helping vesicles move toward the membrane.
Vesicles dock and fuse with the plasma membrane, increasing surface transporter availability in an insulin-responsive state.
Reduced signaling at IRS, PI3K, AKT, AS160, cytoskeleton, or vesicle-fusion nodes can lower insulin-stimulated glucose disposal.
Chapter 05
Separate skeletal muscle, liver, adipose tissue, islet, endothelium, immune-stromal, brain, and bone contexts.
Largest insulin-stimulated glucose-disposal compartment in many clamp models. Key issues include GLUT4 translocation, glycogen synthesis, intramyocellular lipid, DAG/PKCtheta, ceramide, mitochondrial substrate pressure, and capillary delivery.
Insulin normally restrains hepatic glucose production and coordinates glycogen and lipid routing. Selective resistance can leave glucose-output suppression impaired while lipid programs remain active.
Insulin suppresses lipolysis and supports lipid storage. When anti-lipolysis is blunted, fatty acids and glycerol can spill into circulation and feed liver and muscle stress.
Beta cells increase secretory output when insulin demand rises. Compensation can maintain system output for a time, while secretory load can stress ER, mitochondria, granule processing, and proinsulin conversion.
Insulin signaling has PI3K-NO and MAPK/endothelin-like branches. Resistance can become branch-selective, changing vascular tone, adhesion biology, glycocalyx state, and capillary recruitment.
Macrophages, neutrophils, lymphocytes, fibroblasts, and stromal cells can read lipid, glucose, cytokine, hypoxia, and matrix cues, then feed stress signals back into metabolic tissues.
Bone is not passive storage. High-glucose exposure can alter collagen chemistry, osteoblast and osteoclast signaling, marrow immune tone, and matrix quality in model systems.
Nerves, retinal capillaries, lens-like matrix, and barrier tissues are exposed to glucose without relying on GLUT4 in the same way as muscle. This makes local glucose chemistry and capillary stress especially important.
Chapter 06
Describe adipose buffering limits, lipolysis escape, fatty-acid flux, and ectopic lipid as early system stressors.
When lipid storage cannot buffer incoming fuel cleanly, adipocytes can enlarge, remodel matrix, change oxygen tension, and recruit immune-stromal signaling.
Insulin normally restrains ATGL/HSL/perilipin-linked lipolysis. Resistance can raise fatty-acid and glycerol flux even when insulin is present.
Lipid intermediates in liver and muscle, including DAG and ceramide species, can interfere with insulin signaling through PKC, PP2A, or AKT-related mechanisms depending on context.
Higher insulin output can compensate for reduced sensitivity, but persistent high demand can also become part of the feedback architecture being studied.
Chapter 07
Explain selective hepatic insulin resistance: incomplete glucose-output suppression with persistent lipid-program signals.
AKT normally restrains FOXO1-linked gluconeogenic gene programs. Reduced signal fidelity can weaken that brake.
Adipose glycerol and fatty-acid flux can provide substrate and energy context for hepatic glucose production and lipid output.
Glucose-output restraint and lipogenic pathway behavior can diverge. That is why liver insulin resistance cannot be read as one simple failed switch.
Hepatic lipid routing, de novo lipogenesis context, and export pathways can become coupled to systemic insulin demand and substrate pressure.
Chapter 08
Connect DAG, ceramide, PKC, mitochondria, ROS, ER stress, and incomplete substrate handling to signaling interference.
Membrane-associated DAG species can activate PKC isoforms that reduce proximal insulin-signal fidelity in liver and muscle models.
Ceramide species can intersect AKT signaling, phosphatase activity, mitochondrial state, and inflammatory tone in context-specific ways.
Substrate overload can increase incomplete fatty-acid oxidation signals, acylcarnitine patterns, redox pressure, and ROS context.
IRE1, PERK, ATF6, XBP1 splicing, CHOP, and eIF2alpha-linked pathways can connect protein-folding burden to inflammatory and metabolic signals.
Chapter 09
Show how JNK, IKK/NF-kB, SOCS, PTP1B, mTOR/S6K, cytokines, and nutrient-stress nodes can intersect IRS signaling.
Chapter 10
Teach nonenzymatic glycation, AGE/RAGE, polyol flux, hexosamine signaling, PKC, oxidative stress, capillary biology, immune shifts, bone matrix context, retina, kidney-like barriers, nerves, and beta-cell glucotoxicity.
Precision note
The accurate mechanism is nonenzymatic glycation, carbonyl stress, altered redox state, osmotic flux, kinase activation, matrix modification, and capillary signaling. Bone and immune cells are part of that network, but the biology is altered immune-cell function and osteoimmune crosstalk, not a one-step immune command.
Glucose and reactive carbonyl intermediates can modify long-lived proteins, lipids, and nucleic-acid-adjacent structures, forming early glycation products and advanced glycation end products.
AGE-modified matrix and circulating ligands can engage RAGE-like receptors, linking oxidative stress, NF-kB-like transcription, endothelial activation, and immune-cell signaling.
Excess intracellular glucose can route through aldose reductase to sorbitol, consuming NADPH and changing osmotic and redox state, especially in susceptible tissues.
Glucose-derived substrates can feed O-GlcNAc and transcriptional control layers, altering signaling proteins and gene programs.
High glucose can increase DAG and PKC activity in vascular and metabolic cells, affecting permeability, blood-flow signaling, adhesion, and extracellular matrix programs.
Mitochondrial redox pressure and reactive carbonyl species create a shared stress layer that can amplify glycation, inflammation, and endothelial dysfunction.
Ocular tissues experience glucose chemistry directly. Polyol flux, AGE accumulation, oxidative stress, endothelial activation, pericyte-like cell stress, and capillary barrier changes can appear in model systems.
Glomerular-like capillaries, basement membrane, podocyte-like cells, mesangial-like cells, and glycocalyx can respond to AGE/RAGE, PKC, oxidative stress, and matrix-production signals.
Axons and microvessels can be affected by polyol flux, mitochondrial stress, reduced trophic support, ischemia-like microvascular context, and altered Schwann-cell biology in research models.
Endothelial glycocalyx, nitric-oxide signaling, basement membrane thickness, leukocyte adhesion, permeability, and capillary recruitment are central to how glucose exposure spreads across organs.
High-glucose environments can alter neutrophil chemotaxis and oxidative burst, macrophage polarization, inflammasome tone, cytokine output, phagocytosis, and resolution behavior. This is immune dysregulation, not a one-step decrease in immunity.
The precise bone story is not glucose telling immunity to switch off. High-glucose and AGE exposure can stiffen collagen matrix, engage RAGE-like signaling, alter osteoblast and osteoclast function, and change marrow immune-stromal crosstalk.
Chronic glucose exposure can create glucotoxic stress: ER load, mitochondrial redox pressure, altered granule processing, proinsulin conversion stress, and reduced first-phase response in model systems.
Glucose-derived lipid routing, fructose-linked hepatic substrate handling, adipose insulin resistance, and fatty-acid spillover can reinforce each other with hyperinsulinemia and inflammatory tone.
Chapter 11
Place hyperinsulinemia, beta-cell compensation, secretory load, insulin clearance, and decompensation into a feedback map.
When peripheral tissues respond less strongly, beta cells can raise insulin output so the wider system still receives enough signal.
Measured insulin depends on secretion and clearance. Liver insulin extraction and peripheral clearance can change the interpretation of circulating insulin.
Persistent demand stresses ER folding, mitochondria, calcium handling, granule maturation, and proinsulin-to-insulin conversion.
When compensation no longer matches demand, the system can show higher glucose exposure, more glucotoxicity, and weaker beta-cell output. This page explains the mechanism, not diagnosis.
Chapter 12
Match readout categories to the mechanism they can observe and the inference they cannot prove alone.
Can show: Estimate insulin-stimulated glucose disposal under controlled research conditions.
Cannot prove alone: By itself, localize the molecular defect, diagnose a person from a course page, or prove an intervention effect.
Can show: Separate endogenous glucose production from disposal and substrate flux.
Cannot prove alone: Replace tissue assays or prove the complete liver signaling state alone.
Can show: Show glucose, insulin, connecting-segment (C) chain, incretin, and clearance dynamics over time.
Cannot prove alone: Define the exact tissue mechanism without modeling and additional measurements.
Can show: Summarize fasting glucose-insulin relationships in population or screening research.
Cannot prove alone: Measure muscle glucose disposal, beta-cell reserve, tissue lipid stress, or clinical status alone.
Can show: Read IR, IRS, AKT, AS160, GSK3, FOXO1, JNK, IKK, mTOR/S6K, and eNOS-like signal states.
Cannot prove alone: Stand in for whole-body physiology without tissue and time context.
Can show: Profile DAG, ceramide, acylcarnitines, amino-acid patterns, redox pools, and glucose-derived metabolites.
Cannot prove alone: Prove direction of causality without experimental design.
Can show: Measure glycation burden, matrix modification, and receptor-linked inflammatory context.
Cannot prove alone: Prove tissue damage, diagnosis, or product-related change alone.
Can show: Localize capillary structure, matrix deposition, immune-cell clusters, adipocyte size, liver fat, and bone matrix context.
Cannot prove alone: Replace controlled functional readouts or establish human outcomes from a figure.
Chapter 13
Keep catalog records limited to identity, structural context, analytical documentation, and reading a certificate.
This course intentionally avoids catalog recommendations. The topic is too easy to misread as glucose, insulin, appetite, body-weight, or disease-outcome guidance. Catalog records belong in identity, structure, analytical release, and COA-literacy lanes only.
Catalog records document chemical-sequence identity, format, and lot documentation. They do not establish effects on insulin, glucose, appetite, body weight, metabolic health, or any human or veterinary outcome.
Receptor-family or pathway imagery is structural context. It is not a binding claim, outcome claim, use instruction, or evidence that a catalog item changes a biological pathway.
Analytical documents answer identity, purity, contaminant, and release questions. They do not answer physiology, diagnosis, treatment, prevention, or suitability-for-use questions.
Chapter 14
Assemble a full map from carbohydrate exposure to tissue-specific resistance, downstream glucose exposure, feedback loops, and measurement limits.
These sources support the biology and measurement framework. They are not cited as evidence for any catalog material changing insulin, glucose, appetite, body weight, disease risk, or any human or veterinary outcome.
Educational biology context only. This course explains research concepts in sustained hyperglycemia, microvascular stress, glycation, tissue remodeling, and organ-system readouts. Not medical advice, diagnostic evidence, treatment guidance, prevention guidance, dosing guidance, administration guidance, wellness guidance, weight-loss guidance, supplement guidance, or evidence that any catalog item changes glucose handling, disease outcomes, or any biological outcome. Insulin-resistance testing and diagnosis belong to licensed health care professionals. This course explains research concepts and readout categories only. Catalog context, if present, is limited to identity, structural context, analytical documentation, and reading a certificate.
Editorial scope: chemical identity, experimental context, analytical methods, source quality and regulatory boundaries. Source references and stated limitations form part of the material; they should remain attached to quotations or summaries.
Biological systems path
Why it matters
Greater transparency today drives better research tomorrow. We provide the materials and the data so the next breakthrough is one step closer.
Our mission